About Us

/
Eligard

Eligard

/
Eligard
Loading...

Eligard

Category:
Composition: Leuprolide Inj
Strength: 45 mg

Description:

Eligard (Leuprolide Acetate) is a gonadotropin-releasing hormone (GnRH) agonist used primarily to manage advanced prostate cancer. It helps lower testosterone levels in men, thereby slowing the growth of prostate cancer cells. In women, it can be used for conditions like endometriosis and uterine fibroids by reducing estrogen levels.

Eligard is formulated as an extended-release injectable suspension designed for subcutaneous injection, ensuring a sustained release over 1, 3, 4, or 6 months depending on the prescribed formulation.

Uses / Indications:

  • Palliative treatment of advanced prostate cancer
  • Management of endometriosis
  • Treatment of uterine fibroids
  • Sometimes used in precocious puberty
Loading...

Description

Dosage and Administration
  • Administered by a healthcare professional via subcutaneous injection.
  • Dosing frequency depends on the specific formulation (monthly, quarterly, semi-annually).

Always follow the specific dosage and schedule recommended by the doctor.

  • Hot flashes
  • Injection site reactions (pain, redness, swelling)
  • Decreased libido
  • Erectile dysfunction
  • Fatigue
  • Sweating
  • Bone thinning (osteoporosis)
  • Heart problems (rare)
  • Mood changes or depression
  • Increase in blood sugar levels

Contact a healthcare provider if severe side effects or allergic reactions occur.

  • Inform the doctor about any heart conditions, diabetes, or bone density issues.
  • Not recommended for use in pregnant women.
  • Temporary tumor flare (worsening of symptoms) may occur initially.
  • Regular monitoring of PSA (Prostate-Specific Antigen) levels is advised during treatment.